The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pre-Exposure Prophylaxis-Global Market Insights and Sales Trends 2024
Synopsis
PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one's body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
The global Pre-Exposure Prophylaxis market size is expected to reach US$ 327 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pre-Exposure Prophylaxis in various end use industries. The expanding demands from the Adult and Adolescent, are propelling Pre-Exposure Prophylaxis market. Truvada, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Discovy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pre-Exposure Prophylaxis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pre-Exposure Prophylaxis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pre-Exposure Prophylaxis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pre-Exposure Prophylaxis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pre-Exposure Prophylaxis covered in this report include Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science and Lupin, etc.
The global Pre-Exposure Prophylaxis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin
Global Pre-Exposure Prophylaxis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pre-Exposure Prophylaxis market, Segment by Type:
Truvada
Discovy
Global Pre-Exposure Prophylaxis market, by Application
Adult
Adolescent
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pre-Exposure Prophylaxis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one's body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
The global Pre-Exposure Prophylaxis market size is expected to reach US$ 327 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pre-Exposure Prophylaxis in various end use industries. The expanding demands from the Adult and Adolescent, are propelling Pre-Exposure Prophylaxis market. Truvada, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Discovy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pre-Exposure Prophylaxis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pre-Exposure Prophylaxis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pre-Exposure Prophylaxis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pre-Exposure Prophylaxis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pre-Exposure Prophylaxis covered in this report include Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science and Lupin, etc.
The global Pre-Exposure Prophylaxis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin
Global Pre-Exposure Prophylaxis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pre-Exposure Prophylaxis market, Segment by Type:
Truvada
Discovy
Global Pre-Exposure Prophylaxis market, by Application
Adult
Adolescent
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pre-Exposure Prophylaxis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pre-Exposure Prophylaxis Market Overview
1.1 Pre-Exposure Prophylaxis Product Overview
1.2 Pre-Exposure Prophylaxis Market Segment by Type
1.2.1 Truvada
1.2.2 Discovy
1.3 Global Pre-Exposure Prophylaxis Market Size by Type
1.3.1 Global Pre-Exposure Prophylaxis Market Size Overview by Type (2018-2029)
1.3.2 Global Pre-Exposure Prophylaxis Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pre-Exposure Prophylaxis Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pre-Exposure Prophylaxis Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pre-Exposure Prophylaxis Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pre-Exposure Prophylaxis Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pre-Exposure Prophylaxis Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pre-Exposure Prophylaxis Sales Breakdown by Type (2018-2023)
2 Global Pre-Exposure Prophylaxis Market Competition by Company
2.1 Global Top Players by Pre-Exposure Prophylaxis Sales (2018-2023)
2.2 Global Top Players by Pre-Exposure Prophylaxis Revenue (2018-2023)
2.3 Global Top Players by Pre-Exposure Prophylaxis Price (2018-2023)
2.4 Global Top Manufacturers Pre-Exposure Prophylaxis Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pre-Exposure Prophylaxis Market Competitive Situation and Trends
2.5.1 Pre-Exposure Prophylaxis Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pre-Exposure Prophylaxis Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pre-Exposure Prophylaxis as of 2022)
2.7 Date of Key Manufacturers Enter into Pre-Exposure Prophylaxis Market
2.8 Key Manufacturers Pre-Exposure Prophylaxis Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pre-Exposure Prophylaxis Status and Outlook by Region
3.1 Global Pre-Exposure Prophylaxis Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pre-Exposure Prophylaxis Historic Market Size by Region
3.2.1 Global Pre-Exposure Prophylaxis Sales in Volume by Region (2018-2023)
3.2.2 Global Pre-Exposure Prophylaxis Sales in Value by Region (2018-2023)
3.2.3 Global Pre-Exposure Prophylaxis Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pre-Exposure Prophylaxis Forecasted Market Size by Region
3.3.1 Global Pre-Exposure Prophylaxis Sales in Volume by Region (2024-2029)
3.3.2 Global Pre-Exposure Prophylaxis Sales in Value by Region (2024-2029)
3.3.3 Global Pre-Exposure Prophylaxis Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pre-Exposure Prophylaxis by Application
4.1 Pre-Exposure Prophylaxis Market Segment by Application
4.1.1 Adult
4.1.2 Adolescent
4.2 Global Pre-Exposure Prophylaxis Market Size by Application
4.2.1 Global Pre-Exposure Prophylaxis Market Size Overview by Application (2018-2029)
4.2.2 Global Pre-Exposure Prophylaxis Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pre-Exposure Prophylaxis Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pre-Exposure Prophylaxis Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pre-Exposure Prophylaxis Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pre-Exposure Prophylaxis Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pre-Exposure Prophylaxis Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pre-Exposure Prophylaxis Sales Breakdown by Application (2018-2023)
5 North America Pre-Exposure Prophylaxis by Country
5.1 North America Pre-Exposure Prophylaxis Historic Market Size by Country
5.1.1 North America Pre-Exposure Prophylaxis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pre-Exposure Prophylaxis Sales in Volume by Country (2018-2023)
5.1.3 North America Pre-Exposure Prophylaxis Sales in Value by Country (2018-2023)
5.2 North America Pre-Exposure Prophylaxis Forecasted Market Size by Country
5.2.1 North America Pre-Exposure Prophylaxis Sales in Volume by Country (2024-2029)
5.2.2 North America Pre-Exposure Prophylaxis Sales in Value by Country (2024-2029)
6 Europe Pre-Exposure Prophylaxis by Country
6.1 Europe Pre-Exposure Prophylaxis Historic Market Size by Country
6.1.1 Europe Pre-Exposure Prophylaxis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pre-Exposure Prophylaxis Sales in Volume by Country (2018-2023)
6.1.3 Europe Pre-Exposure Prophylaxis Sales in Value by Country (2018-2023)
6.2 Europe Pre-Exposure Prophylaxis Forecasted Market Size by Country
6.2.1 Europe Pre-Exposure Prophylaxis Sales in Volume by Country (2024-2029)
6.2.2 Europe Pre-Exposure Prophylaxis Sales in Value by Country (2024-2029)
7 Asia-Pacific Pre-Exposure Prophylaxis by Region
7.1 Asia-Pacific Pre-Exposure Prophylaxis Historic Market Size by Region
7.1.1 Asia-Pacific Pre-Exposure Prophylaxis Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pre-Exposure Prophylaxis Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pre-Exposure Prophylaxis Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pre-Exposure Prophylaxis Forecasted Market Size by Region
7.2.1 Asia-Pacific Pre-Exposure Prophylaxis Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pre-Exposure Prophylaxis Sales in Value by Region (2024-2029)
8 Latin America Pre-Exposure Prophylaxis by Country
8.1 Latin America Pre-Exposure Prophylaxis Historic Market Size by Country
8.1.1 Latin America Pre-Exposure Prophylaxis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pre-Exposure Prophylaxis Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pre-Exposure Prophylaxis Sales in Value by Country (2018-2023)
8.2 Latin America Pre-Exposure Prophylaxis Forecasted Market Size by Country
8.2.1 Latin America Pre-Exposure Prophylaxis Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pre-Exposure Prophylaxis Sales in Value by Country (2024-2029)
9 Middle East and Africa Pre-Exposure Prophylaxis by Country
9.1 Middle East and Africa Pre-Exposure Prophylaxis Historic Market Size by Country
9.1.1 Middle East and Africa Pre-Exposure Prophylaxis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pre-Exposure Prophylaxis Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pre-Exposure Prophylaxis Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pre-Exposure Prophylaxis Forecasted Market Size by Country
9.2.1 Middle East and Africa Pre-Exposure Prophylaxis Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pre-Exposure Prophylaxis Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Gilead Sciences
10.1.1 Gilead Sciences Company Information
10.1.2 Gilead Sciences Introduction and Business Overview
10.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gilead Sciences Pre-Exposure Prophylaxis Products Offered
10.1.5 Gilead Sciences Recent Development
10.2 Teva Pharmaceuticals
10.2.1 Teva Pharmaceuticals Company Information
10.2.2 Teva Pharmaceuticals Introduction and Business Overview
10.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Products Offered
10.2.5 Teva Pharmaceuticals Recent Development
10.3 Strides Pharma Science
10.3.1 Strides Pharma Science Company Information
10.3.2 Strides Pharma Science Introduction and Business Overview
10.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Products Offered
10.3.5 Strides Pharma Science Recent Development
10.4 Lupin
10.4.1 Lupin Company Information
10.4.2 Lupin Introduction and Business Overview
10.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lupin Pre-Exposure Prophylaxis Products Offered
10.4.5 Lupin Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pre-Exposure Prophylaxis Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pre-Exposure Prophylaxis Industrial Chain Analysis
11.4 Pre-Exposure Prophylaxis Market Dynamics
11.4.1 Pre-Exposure Prophylaxis Industry Trends
11.4.2 Pre-Exposure Prophylaxis Market Drivers
11.4.3 Pre-Exposure Prophylaxis Market Challenges
11.4.4 Pre-Exposure Prophylaxis Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pre-Exposure Prophylaxis Distributors
12.3 Pre-Exposure Prophylaxis Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
